291 related articles for article (PubMed ID: 31217420)
41. Acteoside protects podocyte against apoptosis through regulating AKT/GSK-3β signaling pathway in db/db mice.
Li X; Liu Z; He Z; Wang X; Li R; Wang J; Ma G; Zhang P; Ma C
BMC Endocr Disord; 2023 Oct; 23(1):230. PubMed ID: 37872577
[TBL] [Abstract][Full Text] [Related]
42. An information theoretic approach to insulin sensing by human kidney podocytes.
Pope RJ; Garner KL; Voliotis M; Lay AC; Betin VM; Tsaneva-Atanasova K; Welsh GI; Coward RJ; McArdle CA
Mol Cell Endocrinol; 2020 Dec; 518():110976. PubMed ID: 32750396
[TBL] [Abstract][Full Text] [Related]
43. Role of Sphingolipid Signaling in Glomerular Diseases: Focus on DKD and FSGS.
Mitrofanova A; Drexler Y; Merscher S; Fornoni A
J Cell Signal; 2020 Sep; 1(3):56-69. PubMed ID: 32914148
[TBL] [Abstract][Full Text] [Related]
44. Klotho inhibits renal ox-LDL deposition via IGF-1R/RAC1/OLR1 signaling to ameliorate podocyte injury in diabetic kidney disease.
Jiang W; Gan C; Zhou X; Yang Q; Chen D; Xiao H; Dai L; Chen Y; Wang M; Yang H; Li Q
Cardiovasc Diabetol; 2023 Oct; 22(1):293. PubMed ID: 37891556
[TBL] [Abstract][Full Text] [Related]
45. RNA-binding proteins tristetraprolin and human antigen R are novel modulators of podocyte injury in diabetic kidney disease.
Guo J; Lei M; Cheng F; Liu Y; Zhou M; Zheng W; Zhou Y; Gong R; Liu Z
Cell Death Dis; 2020 Jun; 11(6):413. PubMed ID: 32487989
[TBL] [Abstract][Full Text] [Related]
46. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
[TBL] [Abstract][Full Text] [Related]
47. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
[TBL] [Abstract][Full Text] [Related]
48. Podocyte-specific knockin of PTEN protects kidney from hyperglycemia.
Wang H; Feng Z; Xie J; Wen F; Jv M; Liang T; Li J; Wang Y; Zuo Y; Li S; Li R; Li Z; Zhang B; Liang X; Liu S; Shi W; Wang W
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1096-F1107. PubMed ID: 29361670
[TBL] [Abstract][Full Text] [Related]
49. Pre-B cell colony enhancing factor induces Nampt-dependent translocation of the insulin receptor out of lipid microdomains in A549 lung epithelial cells.
Peng Q; Jia SH; Parodo J; Ai Y; Marshall JC
Am J Physiol Endocrinol Metab; 2015 Feb; 308(4):E324-33. PubMed ID: 25516545
[TBL] [Abstract][Full Text] [Related]
50. Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice.
Nam DH; Lee MH; Kim JE; Song HK; Kang YS; Lee JE; Kim HW; Cha JJ; Hyun YY; Kim SH; Han SY; Han KH; Han JY; Cha DR
Endocrinology; 2012 Mar; 153(3):1387-96. PubMed ID: 22234468
[TBL] [Abstract][Full Text] [Related]
51. Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway.
Wang X; Jiang L; Liu XQ; Huang YB; Wang AL; Zeng HX; Gao L; Zhu QJ; Xia LL; Wu YG
Phytomedicine; 2022 Nov; 106():154400. PubMed ID: 36049428
[TBL] [Abstract][Full Text] [Related]
52. Proteinuria, the podocyte, and insulin resistance.
Fornoni A
N Engl J Med; 2010 Nov; 363(21):2068-9. PubMed ID: 21083394
[No Abstract] [Full Text] [Related]
53. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
[TBL] [Abstract][Full Text] [Related]
54. AGE-Induced Suppression of EZH2 Mediates Injury of Podocytes by Reducing H3K27me3.
Liebisch M; Wolf G
Am J Nephrol; 2020; 51(9):676-692. PubMed ID: 32854097
[TBL] [Abstract][Full Text] [Related]
55. Apelinergic system in the kidney: implications for diabetic kidney disease.
Müller T; Kalea AZ; Marquez A; Hsieh I; Haque S; Ye M; Wysocki J; Bader M; Batlle D
Physiol Rep; 2018 Dec; 6(23):e13939. PubMed ID: 30548130
[TBL] [Abstract][Full Text] [Related]
56. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
[No Abstract] [Full Text] [Related]
57. Qizhi Jiangtang capsule activates podocyte autophagy in diabetic kidney disease by inhibiting phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin pathways.
Zhaoan G; Lina S; Yingying L; Ruifeng LI; Chong L; Ke D; Jing S; Jun S
J Tradit Chin Med; 2023 Aug; 43(4):667-675. PubMed ID: 37454251
[TBL] [Abstract][Full Text] [Related]
58. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
[TBL] [Abstract][Full Text] [Related]
59. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
Zhan H; Jin J; Liang S; Zhao L; Gong J; He Q
Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
[TBL] [Abstract][Full Text] [Related]
60. Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes.
Denhez B; Lizotte F; Guimond MO; Jones N; Takano T; Geraldes P
J Biol Chem; 2015 Jan; 290(1):350-8. PubMed ID: 25404734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
